JP2025508656A5 - - Google Patents
Info
- Publication number
- JP2025508656A5 JP2025508656A5 JP2024543104A JP2024543104A JP2025508656A5 JP 2025508656 A5 JP2025508656 A5 JP 2025508656A5 JP 2024543104 A JP2024543104 A JP 2024543104A JP 2024543104 A JP2024543104 A JP 2024543104A JP 2025508656 A5 JP2025508656 A5 JP 2025508656A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- preparation
- pharmaceutically acceptable
- effective amount
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303376P | 2022-01-26 | 2022-01-26 | |
| US63/303,376 | 2022-01-26 | ||
| PCT/US2023/011639 WO2023146974A2 (en) | 2022-01-26 | 2023-01-26 | Antiviral prodrugs, intermediate- and long-acting formulations and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508656A JP2025508656A (ja) | 2025-04-10 |
| JP2025508656A5 true JP2025508656A5 (https=) | 2026-03-24 |
Family
ID=87472411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543104A Pending JP2025508656A (ja) | 2022-01-26 | 2023-01-26 | 抗ウイルスプロドラッグ、中期及び長期作用型製剤、並びに方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12594292B2 (https=) |
| EP (1) | EP4469061A4 (https=) |
| JP (1) | JP2025508656A (https=) |
| CN (1) | CN118591377A (https=) |
| AU (1) | AU2023213682B2 (https=) |
| CA (1) | CA3247143A1 (https=) |
| WO (1) | WO2023146974A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12173029B2 (en) | 2020-07-24 | 2024-12-24 | The Regents Of The University Of California | Antiviral prodrugs, pharmaceutical formulations, and methods |
| CA3247143A1 (en) | 2022-01-26 | 2023-08-03 | The Regents Of The University Of California | Antiviral prodrugs, intermediate and long-acting formulations, and methods |
| CN117024479A (zh) * | 2023-08-04 | 2023-11-10 | 杭州居维叶生物医药有限公司 | 一种聚乙二醇化磷酸前药及其制备与应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3529478A1 (de) | 1985-08-16 | 1987-02-19 | Boehringer Mannheim Gmbh | 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung |
| US5484908A (en) | 1991-11-26 | 1996-01-16 | Gilead Sciences, Inc. | Oligonucleotides containing 5-propynyl pyrimidines |
| TW393513B (en) | 1991-11-26 | 2000-06-11 | Isis Pharmaceuticals Inc | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| AU3222793A (en) | 1991-11-26 | 1993-06-28 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| DE60025172T2 (de) | 1999-03-18 | 2006-09-21 | Exiqon A/S | Einstufige probezubereitung und bestimmung von nukleinsäure in biologischen proben |
| DE60029314T2 (de) | 1999-03-24 | 2007-07-12 | Exiqon A/S | Verbesserte Synthese für -2.2.1. I Bicyclo-Nukleoside |
| US6734291B2 (en) | 1999-03-24 | 2004-05-11 | Exiqon A/S | Synthesis of [2.2.1]bicyclo nucleosides |
| EP2558466A4 (en) * | 2010-04-14 | 2013-11-13 | Univ California | PHOSPHONATES WITH REDUCED TOXICITY FOR THE TREATMENT OF VIRUS INFECTIONS |
| SG10201800188SA (en) | 2013-03-15 | 2018-02-27 | Univ California | Acyclic nucleoside phosphonate diesters |
| LT3043803T (lt) * | 2013-09-11 | 2022-08-10 | Emory University | Nukleotidų ir nukleozidų kompozicijos ir jų panaudojimas |
| CN111808136B (zh) | 2014-09-15 | 2024-06-11 | 加利福尼亚大学董事会 | 核苷酸类似物 |
| TWI687432B (zh) | 2014-10-29 | 2020-03-11 | 美商基利科學股份有限公司 | 絲狀病毒科病毒感染之治療 |
| EP3350191B9 (en) | 2015-09-15 | 2021-12-22 | The Regents of the University of California | Nucleotide analogs |
| US10874683B2 (en) | 2016-03-10 | 2020-12-29 | Emory University | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| CA3075950A1 (en) | 2017-09-18 | 2019-03-21 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| TWI791193B (zh) * | 2020-02-18 | 2023-02-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| WO2021222535A1 (en) | 2020-05-01 | 2021-11-04 | Irazu Bio | Method for treating respiratory viral infections comprising administration of fatty acid compositions |
| US12173029B2 (en) | 2020-07-24 | 2024-12-24 | The Regents Of The University Of California | Antiviral prodrugs, pharmaceutical formulations, and methods |
| IL300412A (en) | 2020-08-24 | 2023-04-01 | Gilead Sciences Inc | Phospholipid compounds and their uses |
| TW202344257A (zh) * | 2020-10-16 | 2023-11-16 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| TW202317144A (zh) | 2021-06-14 | 2023-05-01 | 美商維納拓爾斯製藥公司 | 口服生物可利用的核苷類似物 |
| CA3247143A1 (en) | 2022-01-26 | 2023-08-03 | The Regents Of The University Of California | Antiviral prodrugs, intermediate and long-acting formulations, and methods |
| WO2024159117A1 (en) | 2023-01-26 | 2024-08-02 | The Regents Of The University Of California | Antiviral prodrugs, intermediate-and long-acting formulations, and methods |
-
2023
- 2023-01-26 CA CA3247143A patent/CA3247143A1/en active Pending
- 2023-01-26 US US18/833,747 patent/US12594292B2/en active Active
- 2023-01-26 EP EP23747606.4A patent/EP4469061A4/en active Pending
- 2023-01-26 WO PCT/US2023/011639 patent/WO2023146974A2/en not_active Ceased
- 2023-01-26 CN CN202380016345.3A patent/CN118591377A/zh active Pending
- 2023-01-26 JP JP2024543104A patent/JP2025508656A/ja active Pending
- 2023-01-26 AU AU2023213682A patent/AU2023213682B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508656A5 (https=) | ||
| JP7802365B2 (ja) | ハンタウイルス感染症の処置のためのｍｅｋ阻害剤 | |
| DK168514B1 (da) | Synergistisk produkt indeholdende en kombination af amantadin og selegilin, fremgangsmåde til fremstilling af produktet og anvendelse af amantadin og selegilin til fremstilling af produktet | |
| JP2009535352A5 (https=) | ||
| JP2017531038A5 (https=) | ||
| JP2023166406A5 (https=) | ||
| JP2025508942A5 (https=) | ||
| JP2023520323A5 (https=) | ||
| JP2022537047A5 (https=) | ||
| HRP20240501T1 (hr) | Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije | |
| JP2018523635A5 (https=) | ||
| EA022840B1 (ru) | Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа | |
| JP2022531251A5 (https=) | ||
| JP2023540149A (ja) | 抗ウイルス化合物の製剤 | |
| JPWO2023054732A5 (https=) | ||
| JP2023535744A5 (https=) | ||
| JP2010285436A5 (https=) | ||
| CA2991156A1 (en) | Compositions and methods for the treatment of viral infection | |
| JP2016147914A (ja) | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | |
| JP2022534776A5 (https=) | ||
| CA2373833A1 (en) | Medicinal compositions for preventing or treating viral myocarditis | |
| JP2022546424A5 (https=) | ||
| JP2023502053A5 (https=) | ||
| JP2005507944A5 (https=) | ||
| JP2024528237A5 (https=) |